Profibrinolytic, antithrombotic, and antiinflammatory effects of an insulin-sensitizing strategy in patients in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.

Sobel, Burton E; Hardison, Regina M; Genuth, Saul; Brooks, Maria M; McBane, Robert D; Schneider, David J; Pratley, Richard E; Huber, Kurt; Wolk, Robert; Krishnaswami, Ashok; Frye, Robert L

Sobel, Burton E; Hardison, Regina M; Genuth, Saul; Brooks, Maria M; McBane, Robert D; Schneider, David J; Pratley, Richard E; Huber, Kurt; Wolk, Robert; Krishnaswami, Ashok; Frye, Robert L.

Affiliation

Sobel BE; Cardiovascular Research Institute, University of Vermont, Colchester Research Facility, Colchester, VT 05446, USA. Burton.Sobel@uvm.edu

Circulation ; 124(6): 695-703, 2011 Aug 09.

Article in En | MEDLINE | ID: mdl-21768545

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thrombophilia / Coronary Disease / Diabetes Mellitus, Type 2 / Hypoglycemic Agents Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Circulation Year: 2011 Document type: Article Affiliation country: Country of publication:

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google